Examining mCRC Chemotherapy Costs, Patient Outcomes in Washington vs. British Columbia
SCCA's Todd Yezefski, MD, spoke to Targeted Oncology about the results of a clinical trial investigating cost of treatment and outcome differences for patients with colorectal cancer in Washington versus British Columbia.
